above, the first of these is dissimilar tissue distributions. Equally striking is the fact that while H-2 antigens display extraordinary structural polymorphism (16) (17) (18) , Qa antigens exhibit extremely low polymorphism (12, 19) .
One of the first lines of evidence indicating that H-2K and H-2D antigens were derived from a common primordial gene was the detection of cross-reactive or "public" H-2 specificities shared by K and D region antigens (20) . This hypothesis has subsequently been substantiated by both biochemical and molecular genetic data (reviewed in reference 21). It might therefore seem reasonable to expect that if other Class I-like gene products are expressed on cell surfaces, either as differentiation antigens during ontogeny or on subpopulations of adult cells, they might be detected by cross-reactions with anti-Class I (MHC) antibodies.
In this laboratory a series of -50 monocional antibodies (MAb) reacting with a variety of Class I antigens has been produced (22) (23) (24) (25) . During the routine use of one of these antibodies as a negative control on a cell population to which it was not expected to react, reactivity with subpopulations of splenic lymphocytes was observed. As shown in this report, further study of this cross-reaction indicated that the antigen detected was determined by gene(s) mapping to the right of the H-2D region, and that the antigen was expressed preferentially on a subpopulation of peripheral lymphoid cells. Subsequent studies have shown that at least one other Class I specific monoclonal antibody also cross-reacts with this new antigen. In this report we present data characterizing the expression of this antigen at both genetic and cellular levels, and discuss the implications of these findings for the evolution of MHC systems.
Materials and Methods
Animals. Adult male and female mice used were either bred in our own colonies or purchased from the Jackson Laboratory (Bar Harbor, ME). B6.K3 (L. Flaherty) and BALB.A11 (D. H. Sachs) are newly derived recombinant congenic strains that will be described in the Results. C3H.KBR mice are recombinants derived from F2 between C3H/HeJ and C3H.SW (26) . B6-H-2 k mice were provided by Dr. R. H. Schwartz, NIH and were bred from stock originally supplied by Dr. E. A. Boyse. Reagents. The anti-MHC monoclonal antibodies used have been previously described (23-25, 27, 28) . D3.262 is an IgM monoclonal anti-Qa 2 antibody described elsewhere (9) . Fluorescein-labeled Rabbit F(ab)'2 anti-mouse IgG2a was produced under contract NCI-CB-53912-31 and was provided by Dr. H. B. Dickler, NIH. Fluorescein-conjugated (FITC) Goat F(ab)'2 was the gift of B.J. Fowlkes and Dr. R. Asofsky, NIH. Biotin-labeled anti-I-A k monoclonal antibody 10-2.16 (27) and biotin-labeled anti-I-A b monoclonal antibody 25-9-17 (24) were kindly provided by J. Titus, NIH. Biotin-labeled anti-mouse Thy-1.2 (Clone 30-H-12) was purchased (Cat# 1331) from Becton-Dickinson FACS Systems (Sunnyvale, CA). Texas-red conjugated avidin (TRA) was prepared as described previously (29) , and was the gift of J. Titus, NIH.
Two monoclonal anti-MHC antibodies were purified by protein A column separation and were fluorescein conjugated. These were 20-8-4 , an IgG2a, kappa product of a C3H anti-C3H.SW immunization and fusion to SP2/0 Agl4, and 34-1-2, an IgG2a (kappa) product of a C3H anti-BDF~ immunization. For some experiments, 0.2-ml aliquots of a 1:8 dilution of monoclonal antibody 20-8-4 were absorbed with 6 × 108 normal spleen cells of various strains for 60 min at 4°C.
hnmunofluorescence Staining. Spleen, lymph node, and thymus cells were prepared by gentle teasing of the organs with forceps followed by passage through nylon mesh to remove clumps. Bone marrow single cell suspensions were prepared by flushing of femurs and tibias using a 25-gauge needle followed by resuspension through a 25-gauge needle and passage through nylon mesh to remove clumps. Cell suspensions were prepared in Hanks' Balanced Salt Solution containing 10% fetal calf serum, and all further procedures were performed using Hanks' Balanced Salt Solution without phenol red containing 0.1% bovine serum albumin and 0.1% sodium azide.
For indirect one-color staining, 1 x 106 cells were incubated at 4°C for 45 min with unconjugated antibody, washed twice by centrifugation, incubated at 4°C for 45 min with a fluorescein-conjugated anti-mouse immunoglobulin reagent, washed twice again, and finally resuspended and analyzed for fluorescence. For two-color immunofluorescence staining, 1 x 106 cells were incubated at 4°C for 45 min with fluorescein-conjugated antibody, washed twice, incubated at 4°C for 45 rain with biotin-conjugated antibody, washed twice, and incubated at 4°C for 20 rain with Texas-red avidin. Following this incubation, cells were washed twice, resuspended, and analyzed for fluorescence. Controls were performed to show that the resulting fluorescence using this staining method was identical by FMF analysis with cells were reacted with either set of reagents in separate samples or with both sets of reagents in a single sample. These controls demonstrated that there were no competitions or cross-reactions between the reagents used for green (fluorescein) fluorescence and those for red (Texas-red) fluorescence.
For inhibition experiments, 1 x 106 cells were incubated at 4°C for 60 rain with antibody being tested for blocking activity. After 60 rain, fluorescein-conjugated antibody was added in limiting amounts and the incubation was continued at 4°C for 20 rain. Following this incubation, cells were washed twice, resuspended, and analyzed for fluorescence.
Flow Microfluorometry (FMF) Analysis. FMF analysis was performed as previously described (30) using a B-D Dual Laser FACS II (Becton-Dickinson FACS Systems, Sunnyvale, CA). Fluorescein isothiocyanate (FITC) was excited at 488 nm and Texas-red was excited at 568.2 nm. Data on individual cells were collected, stored, displayed, and analzyed using a PDP 11/34 computer (Digital Equipment Corporation, Maynard, MA) interfaced to the FACS II (31) . Fluorescence data were collected using either linear or logarithmic amplification, on 50,000 viable cells as determined by forward light scatter intensity. Logarithmic amplification was provided by a 3-decade logarithmic amplifier constructed from an NIH-modified design of R. Hiebert, LASL (Los Alamos, NM). One-color fluorescence data are displayed as cell frequency histograms or immunofluorescence (IF) profiles in which logarithmically increasing fluorescence intensity is plotted in 1024 channels on the x-axis and cell number is shown on the y-axis. Two-color immunofluorescence data are displayed as contour diagrams in which increasing intensities of green (FITC) fluorescence were plotted in 64 channels on the x-axis and increasing intensities of red (Texas-red) fluorescence were plotted on the y-axis. Arbitrary levels were selected on the z-axis which contained the number of cells at any intersection of x and y values. These levels resulted in rings or contours around the peaks of cells correlating red and green fluorescence.
Data from inhibition experiments were calculated by the formula:
where FI ---linear units of fluorescence intensity; exp = cells stained with FITC-Antibody in the presence of a potential inhibitor; con = cells stained with FITC-Antibody in the presence of media; and bkg = unstained cells.
Results
Unexpected Reactivity of . , an IgG2a product of a C3H
anti-C3H.SW immunization, was originally characterized by antibody and complement cytotoxicity on a panel of inbred and recombinant inbred mouse strains. (Fig. 1 a) characteristic of spleen cells stained with anti-Class I MHC antibodies (32, 33) , a pattern of reactivity which suggested that all spleen cells bore equivalent amounts of Class I antigens. In contrast, reaction of 20-8-4 with the same B10 spleen cells unexpectedly gave a bimodal IF profile (Fig. 1 b) , which was of a similar intensity level to that observed for 28-8-6. Table I , the strain distribution correlated with that of the Qa 2a(Qa 4a), Qa 3 and Qa 6 alleles (see footnote II, Table I ), but not with the distribution of Qa 1, Tla, or Qa 5, 7, 8 alleles.
In order to further map this CR antigen, two new recombinants were employed. The first of these was the BALB.A 11, a new H-2" recombinant derived from a backcross of (BALB.K × BALB/cKh)Fl to BALB/cKh. The BALB/cKh subline, as described previously (35) The overall intensity of staining of 20-8-4 on the B6.K3 cells (Fig. 3e ) was significantly higher than that seen when 20-8-4 reacted with A/J cells (Fig. 3 c) . The mapping studies and strain distribution analysis summarized in Table I therefore showed that the 20-8-4 MAb not only reacted with H-2 Class I antigens (Kb,K ~, DS,r) as previously demonstrated, but also cross-reacted with an antigen not controlled by genes within the H-2 region, but rather by linked genes outside of H-2. Furthermore, these studies showed that the expression of this antigen was correlated with expression of Qa 2.
Inhibition of 20-8-4 Reactivity. In order to analyze further the determinants detected by the 20-8-4 CR, a variety of antibodies were analyzed for their ability to block 20-8-4 FITC reactivity. The antibodies tested were either anti-Class I MHC antibodies or antibodies with no specificity for H-2 antigens, but reactive to Qa region antigens. The results of these studies are shown in Table II ies were also analyzed for their ability to block 34-1-2 CR reactivity on B10.A(2R) spleen cells. The staining in this case was identical to that of 20-8-4 staining, showing a bimodal profile. As the data in Table II In summary, the inhibition experiments showed that two anti-Class I MHC MAbs, 20-8-4 and 34-1-2, also detect identical or spatially related determinants on an antigen(s) determined by genes that map to the right of the H-2 region. Antibodies present in an antiserum against products of this region also detected this determinant or spatially related determinants, while a monoclonal anti-Qa 2 antibody, D3.262 did not.
Tissue Distribution of the CR Antigen Detected by 20-8-4 . The expression of the antigen detected by the 20-8-4 CR was studied on spleen, lymph node, thymus, and bone marrow cells using immunofluorescence and FMF analysis. To assess further the relative reactivities of 20-8-4 and D3.262 (anti-Qa 2), these MAbs were studied with B10.A(2R) and B10.A bone marrow cells (Fig. 6) . The IF profile obtained with 20-8-4 on B10.A(2R) bone marrow cells (Fig. 6a) showed three subpopulations: negative cells (78% of total), dull positive cells (16%), and bright cells (6%). The small bright subpopulation was of the same intensity as the bright subpopulation of positive spleen cells and the small positive subpopulation of thymocytes from the same animal (Fig. 6a vs. Fig. 5, a and c) . The reactivity of D3.262 with the same bone marrow cells (Fig. 6, c and d ) was very different from that found with 20-8-4. One striking observation was that the overall intensity of staining did not differ between the two strains, such that B10.A bone marrow cells were of the same intensity as those from B 10.A(2R). When spleen cells from the same animals were analyzed with D3.262, B10.A(2R) Ig-cells were only 1.5 times brighter than B10.A Ig-cells (data not shown). In addition, the shape of the IF profiles shown in Fig. 6 suggested that most bone marrow cells from both strains were positive with D3.262, although only 40% (B10.A(2R)) and 36% (B10.A) were clearly positive after subtraction of background.
B10.A(2R) Bone Marrow
The tissue distribution analysis of the antigen detected by the 20-8~ CR demonstrated that this antigen was expressed on most, if not all spleen cells, but only on small subpopulations of thymus and bone marrow cells. Spleen and lymph node cells (see below) gave similar IF profiles and each clearly contained two subpopulations that differed significantly in their levels of expression of this antigen. Finally, the expresion of the CR antigen was different on bone marrow cells than that of Qa 2, as defined by the D3.262 monoclonal antibody. Table I ). B10.A(2R) spleen cells contained Thy-l.2-positive, 20-8-4 bright cells (Fig. 8a) , and I-A k positive, 20-8-4 dull cells (Fig. 8 b) , a result compatible with data shown in Fig. 7 . In contrast, when subpopulation analysis of C3H.KBR (Kb,Ib,Dk,Qa 2 b) spleen cells was performed, the 20-8-4 antibody did not discriminate between T cells and B cells (Fig. 8, c and d) . Thus, Thy-1.2 positive cells were of the same green fluorescence (20-8-4 ) intensity as Thy-l.2-negative cells (Fig. 8c) . have been found that cross-react with this H-2 CR antigen. The cross-reactive determinant(s) is expressed on an antigen that can be tentatively classified as a Qa antigen by genetic mapping as well as strain and tissue distribution. In addition, an antiserum specific for products of the Qa/Tla region blocks reactivity of the anti-Class I MHC antibodies with the H-2 cross-reactive (CR) antigen. Although the reaction of anti-Class I MHC MAbs with this H-2 CR antigen is inhibited by B6.K1 anti-B6 serum, the determinants being detected by the serum and the MAbs must be different. Both MAbs react strongly with K b, while the B6.K1 animal, which itself expresses K b, would not be expected to produce detectable antibodies reactive with this antigen. Consistent with this expectation, reactivity of the MAbs to K b itself, rather than the H-2CR antigen, is not inhibited by B6.K1 anti-B6 serum (data not shown). Therefore, it seems likely that the B6.K1 anti-B6 serum and the anti-H-2 MAbs detect distinct, but spatially related determinants on the same epitope of the H-2 CR antigen. One prediction of this analysis is that cross-reactive antibodies such as the ones described in the present study might be readily detected only in immunizations in which the responder animal and the immunizing cells differ at H-2.
Two-Color Immunofluorescence
The Tla region of the mouse genome located telomeric to H-2D is known to contain at least two subregions on the basis of recombinant events between Qa 2 and TL (12) . Both TL antigens and the Qa 1 antigen are controlled by the TL subregion and consist of specificities distinct from the H-2 CR antigen reported in the present study on the basis of strain distribution (see Table I ). Qa 6 is thought to be controlled by loci within the TL subregion (37), while Qa 2-5,7,8 are controlled by the Qa subregion (12, 38) . While differences in thymus, bone marrow, and B cell expression have been reported for these antigens, they are all expressed predominantly on peripheral T cells (12, 37, 38) as is the CR antigen described in the present study. Qa 2-8 antigens also share similar, but not identical, strain distributions distinguished by the fact that only strains that are Qa 2 positive express any of the remaining Qa 3-8 specificities (12, 37, 38) . The CR antigen reported here appears to be distinct from Qa 5,7,8 on the basis of strain distribution (see Table I ). While the expression of the CR antigen correlates with that of Qa 2,3,6 by strain distribution, it appears to be distinct because (a) the reactivity of 20-8-4 with the CR antigen is not inhibited by the D3.262 (anti-Qa 2) MAb; (b) the expression of this CR antigen on bone marrow cells, as shown in this study, is markedly different from that of Qa 2 as detected by D3.262; (c) two other recently described anti-Qa 2 MAbs have been reported to identify B cell subpopulations (10, 1 I), while the 20-8-4 reaction with the CR antigen does not; (d) Unlike Qa 3 and Qa 6 which have not been detected on thymocytes (12, 38) , the CR antigen has been found on ~5% of thymocytes. Therefore, if one considers previous reports on Tla region antigens, it appears that the anti-Class I MAb cross-reactivity described here detects a previously undefined Qa antigen or specificity. However, there is sufficient ambiguity in the definition of previously defined Qa antigens to make overlap possible, and we have therefore not assigned a definite Qa specificity for the CR antigen to date. The data presented here illustrate that analysis of this type of antigen with MAbs and flow microfluoremetry permits highly reproducible and sensitive quantitation on different cellular subpopulations and mouse strains, thus providing less ambiguous definition of the antigen than has previously been described.
Recent molecular analyses of the mouse genome (reviewed in detail, reference 21) have demonstrated the existence of numerous DNA sequences that cross hybridize with H-2 Class I DNA probes, suggesting that these sequences may constitute a large gene family derived from a common ancestral gene (3, 4) . It has been suggested that genes linked to H-2, even if unexpressed in normal tissues, may somehow be involved in the generation of H-2 polymorphism, possibly by a gene conversion mechanism (40) (41) (42) . In addition, some or all of these genes may be expressed in a different fashion from classical Class I products. Rather than being expressed ubiquitously, they could, for example, be expressed only on specific tissues or at certain times during ontogeny. As such, these antigens could serve differentiation or tissue-specific functions.
By definition, the new Qa determinant(s) described in this study shares serological cross-reactivity with classical H-2 Class I MHC antigens. Serologicaily cross-reactive anti-Qa 1 alloantisera detecting H-2 Class I antigens (K f) have previously been reported (43, 44) , although anti-Qa cross-reactivity in anti-H-2 K f alloantisera could not be detected (43) . In addition, reactivity to Qa 2 by anti-K b alloantisera has been reported (45) . However, such sera are composed of complex mixtures of antibodies, and the basis of the cross-reactions is therefore more difficult to interpret. In the present study, the same MAbs shown to crossreact with a Qa-like antigen also react with known H-2 products. In fact, these two MAbs are extremely cross-reactive among H-2 Class I antigens (24, 25) and have recently been reported to detect two H-2K products in the H-2 d haplotype (46) . Serologic cross-reactivity between the products of H-2 Class I MHC genes and those of genes telomeric to H-2D suggests that these genes may share a common origin and structure. This antigen therefore fits precisely the characteristics predicted for a product of one of the many Class I-like genes defined by DNA hybridization studies but previously unrecognized as an expressed gene. Confirmation of this prediction must await identification of the gene responsible for the CR specificity, and studies using L cell transformants bearing Class-Ilike genes are in progress for this purpose.
A parallel of possible significance can be drawn between the lymphoid expression of this CR antigen and of Ia antigens. Both are determined by H-2-1inked genes and both show a more limited tissue distribution than do Class I H-2 antigens. By two-color immunofluorescence analysis, there is an almost completely inverse correlation between I-A antigen and H-2 CR antigen expression on spleen and lymph node cells. This inverse relationship may be fortuitous, or it may provide a clue to the possible function of the CR antigens in cellular immune interactions. The availability of MAbs which react with both Class I and Class I-like gene products also has possible practical implications. Because each of these antibodies reacts with both H-2 and non-H-2 antigens derived from genes with striking homologies, a single probe can now be used to analyze similarities in the products of these genes. These antibodies may also be useful in analysis of factors which control the differences in tissue and temporal expression of H-2 vs. H-2-1inked homologous genes.
Suillmary
Analysis of anti-Class I major histocompatibility complex (MHC) monoclonal antibodies by immunofluorescence and flow microfluorometry demonstrated an unexpected cross-reactivity. Two of fifteen antibodies examined (20-8-4 , antiKb,Kd,r,s and 34-i-2, antiKd,Dd,Kb, r,s,q,p) were observed to detect an antigen determined by gene(s) mapping to the right of H-2D. Two-color immunofluorescence analysis demonstrated that this antigen, unlike classical H-2K and D antigens, was expressed in high amounts on peripheral T cells, but only weakly on Ia-positive cells and on small subpopulations of thymus and bone marrow cells. Mapping, absorption, blocking, and tissue distribution studies suggested that the cross-reactive antigen is Qa-like, but distinct from previously described Qa antigens. Thus, these data demonstrate serological cross-reactivity between a Class I MHC antigen and a differentiation antigen determined by genes linked to H-2. It seems likely that the gene responsible for this new antigen is one of the numerous Class I-like sequences detected by DNA hybridization analyses, but previously undefined in terms of tissue expression. These data suggest that many of these DNA sequences may be expressed in specific tissues and that crossreactions of anti-Class I MAbs may provide useful probes for studying the products of such homologous genes.
